Skip Navigation

Advertise|Press|Contact|FAQ|CWConnect

Bookmark/Print/Share

Home » Clinical Trials » Therapeutic Areas
Therapeutic Areas: Oncology | Family Medicine
 Disease Category: Solid Tumors
Location: United States, CA

Trial Information

A Phase 1, Multi-Center, Open-Label, Dose Escalation Study of I-131-CLR1404 in Subjects with Relapsed or Refractory Advanced Solid Malignancies

The main purpose of this study is to determine the recommended dose of the radioactive drug I-131-CLR1404 for treating people with cancer that either does not respond to treatment or has returned. The recommended dose that is determined in this study will be used as the optimal dose of I-131-CLR1404 in future research studies.The study will also look at the safety and pharmacokinetics of I-131-CLR1404 and determine its preliminary anti-tumor activity. Pharmacokinetics (PK) is the study of how long a drug stays in the body and how the body gets rid of the drug.

Patient Inclusion/Exclusion Criteria:


- See http://clinicaltrials.coh.org for additional information.


City of Hope
1500 East Duarte Road
Duarte, CA 91010-3000
Phone: 866-896-HOPE (4673)

View Map

Research Center Information: City of Hope

DISCLAIMER: This site is run by CenterWatch, a publishing company that focuses on the clinical trials industry. The information provided in this service is designed to help patients find clinical trials that may be of interest to them, and to help patients contact the centers conducting the research. CenterWatch is neither promoting this research nor involved in conducting any of these trials.